Digital image correlation vibrometry with low speed equipment

A low-cost method is presented which enables digital image correlation (DIC) with conventional cameras (i.e. not high-speed) to be used for determination of vibration deflected shapes via the use of a stroboscopic lamp and some simple ancillary circuits. For each natural frequency of the structure under consideration, a sequence of images is captured asynchronously with the vibrations using the DIC system and the resulting displacement fields are correlated with the excitation signal driving the vibration using a least-squares approach. Three approaches for performing this correlation are outlined, one of which is developed into the algorithm used for processing the present results to obtain the amplitude and phase of the vibration at each point on the specimen, allowing the deflected shape to be reconstructed. This process is illustrated using the example of a vibrating aluminium plate. The resulting shapes and frequencies agree well with finite element modal analyses of the plate

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

Objectives: To assess the efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis (RA) and poor prognostic factors. Methods: In this double-blind, phase IIIb study, patients with RA for 2 years or less were randomly assigned 1 : 1 to receive abatacept (similar to 10 mg/kg) plus methotrexate, or placebo plus methotrexate. Patients were methotrexate-naive and seropositive for rheumatoid factor (RF), anti-cyclic citrullinated protein (CCP) type 2 or both and had radiographic evidence of joint erosions. The co-primary endpoints were the proportion of patients achieving disease activity score in 28 joints (DAS28)-defined remission (C-reactive protein) and joint damage progression (Genant-modified Sharp total score; TS) at year 1. Safety was monitored throughout. Results: At baseline, patients had a mean DAS28 of 6.3, a mean TS of 7.1 and mean disease duration of 6.5 months; 96.5% and 89.0% of patients were RF or anti-CCP2 seropositive, respectively. At year 1, a significantly greater proportion of abatacept plus methotrexate-treated patients achieved remission (41.4% vs 23.3%; p<0.001) and there was significantly less radiographic progression (mean change in TS 0.63 vs 1.06; p = 0.040) versus methotrexate alone. Over 1 year, the frequency of adverse events (84.8% vs 83.4%), serious adverse events (7.8% vs 7.9%), serious infections (2.0% vs 2.0%), autoimmune disorders (2.3% vs 2.0%) and malignancies (0.4% vs 0%) was comparable for abatacept plus methotrexate versus methotrexate alone. Conclusions: In a methotrexate-naive population with early RA and poor prognostic factors, the combination of abatacept and methotrexate provided significantly better clinical and radiographic efficacy compared with methotrexate alone and had a comparable, favourable safety profile

Experiment to study the. beta. -decay of free atomic and molecular tritium. [For determining antineutrino mass]

An apparatus is described which will allow the measurement of the ..beta..-decay of free tritium atoms and molecules for determining antineutrino mass. It consists of an RF dissociator, a long cylindrical decay region open at both ends, a guide field, and a magnetic spectrometer